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Abstract
Evolution has provided a number of animal species with extraordinary phenotypes. Several of
these phenotypes allow species to survive and thrive in environmental conditions that mimic
disease states in humans. The study of evolved mechanisms that responsible for these phenotypes
may provide insights into the basis of human disease and guide the design of new therapeutic
approaches. Examples include species that tolerate acute or chronic hypoxemia like deep-diving
mammals and high-altitude inhabitants, as well as those that hibernate and interrupt their
development when exposed to adverse environments. The evolved traits exhibited by these animal
species involve modifications of common biological pathways that affect metabolic regulation,
organ function, antioxidant defenses, and oxygen transport.
In 2006, the National Heart, Lung, and Blood Institute (NHLBI) released a funding opportunity
announcement to support studies that were designed to elucidate the natural molecular and cellular
mechanisms of adaptation in species that tolerate extreme environmental conditions. The rationale
for this funding opportunity is detailed in this Special Article, and the specific evolved
mechanisms examined in the supported research are described. Also highlighted are past medical
advances achieved through the study of animal species that have evolved extraordinary
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phenotypes as well as the expectations for new understanding of nature’s solutions to heart, lung,
blood, and sleep disorders through future research in this area.
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Introduction
In 2007, cardiovascular, respiratory, and blood diseases accounted for over 1 million deaths
and 43% of all deaths in the United States.1 Of all diseases, heart disease is the leading cause
of death, cerebrovascular disease is third (behind cancer), and chronic obstructive
pulmonary disease (COPD) ranks fourth.1 Despite a 12% decline in the number of deaths
from heart, lung, and blood diseases from 1987 to 2007, the public health burden and
economic costs remain high,1, 2 and new effective interventions and treatments are needed.
Innovative research approaches will improve understanding of the molecular and
physiologic basis of human health and disease. One successful and often unexploited
strategy in biomedical research is to examine naturally-occurring variations in animal
species that are adapted to extreme environments. This approach follows August Krogh’s
principle that “for a large number of problems, there will be some animal of choice or a few
such animals on which it can be most conveniently studied.”3 Krogh’s principle is based on
the observation that some organisms are particularly well-suited for studying specific
problems that affect humans—i.e., they have evolved phenotypes that either exemplify a
phenomenon observed in humans, mimic essential aspects of a particular human disease, or
permit a unique study approach. Krogh believed that these specialized adaptations could and
should be exploited to solve specific biological problems.
One example of the application of Krogh’s principle that advanced biomedical knowledge is
the work performed on electric rays (Torpedo californica) and eels (Electrophorus
electricus). These species were studied because they represented explicit examples of
“animal electricity,”4, 5 characterized by their specialized electric organs, which allowed
them to generate electrical fields for communication, navigation, predation, and defense
without shocking themselves. Work on electric rays and eels resulted in fundamental
understanding of the molecular properties of acetylcholine receptors and membrane-bound
ion channels.6
Venoms, another evolved strategy in some animal species for self-defense and seeking prey,
initially piqued the interest of scientists because of their paralyzing potency.7 The study of
venom from sessile marine mollusks (genus Conus), resulted in the identification of several
conotoxins, peptides with high affinities for human ion channels.8 One of these peptides, ω-
conotoxin MVIIA from Conus magnus, selectively blocks N-type voltage-gated Ca2+
channels, which control norepinephrine release from cardiac sympathetic nerves9 and other
neural pathways.10 ω-Conotoxin MVIIA’s synthetic equivalent, Ziconotide, is FDA-
approved for treating neuropathic pain in cancer and AIDS patients,11 and it has therapeutic
potential for ischemic stroke12 and other cardiovascular, respiratory, and blood diseases.
Similarly, studies of venom from the American funnel web spider (Agelenopsis aperta)
identified peptides with high affinities for ion channels in humans and other species.13 One
such peptide, ω-agatoxin IIA, specifically targets T-type and N-type voltage-gated Ca2+
channels, involved in the development of congestive heart failure, hypertension, and
epilepsy.14 Further studies with ω-agatoxin IIA may offer new therapeutic strategies for
treating and preventing these diseases. The study of vampire bats (Desmodus rotundus) also
supports Krogh’s principle. Bites inflicted by these bats were known to bleed freely for
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several hours after they finished feeding,15 and biomedical investigators were interested in
understanding how vampire bat saliva prevented blood coagulation in the host animal so that
this knowledge might be used to improve therapeutic outcomes in people suffering from
hypercoagulability syndromes and other cardiovascular disorders. These studies led to the
characterization of plasminogen-activating proteins in vampire bat saliva,16 which
subsequently resulted in the development and Phase III clinical trial testing of
Desmoteplase,17 a new anticoagulant for stroke treatment.18
Krogh’s principle has also been applied in research aimed at understanding the nervous
system by using animal models with unique phenotypes. Giant axons from squid (Loligo
ssp), were ideal for studies designed to elucidate the bases of neural activity because of their
large physical size, which allowed the placement of recording electrodes across the
membrane of a single neuron. This ability allowed the development of voltage-clamp
techniques to measure changes in the membrane current underlying the development of an
action potential, and it also spurred the development of experimental protocols to decipher
the ionic bases of those currents. This pioneering work in giant squid axons led to the
fundamental understanding of the ionic bases for resting and action potentials in nerves19
and other excitable tissues, including heart.20 Similarly, the investigation of sea slugs (genus
Aplysia) was undertaken because they possessed a relatively small number of large nerve
cells that were easily identified and could be individually mapped.21, 22 Sea slugs exhibited
a siphon-withdrawal response mediated by electrical synapses that allowed several neurons
to fire simultaneously to permit a rapid reaction to danger.23 The unique configuration of
synapses in these species aided studies that were designed to elucidate the basis of
memory.21–23
Comparative biology has also identified species with unique phenotypes that naturally
mimic or accentuate aspects of human disease conditions. For example, “fainting goats,”
who suffered skeletal muscle rigidity and collapsed when startled, appeared to share
symptoms of human congential myotonia, a neuromuscular disease characterized by slow
muscle relaxation after contraction or electrical stimulation. Studies demonstrated that
before stimulation, resting muscle fibers from this strain of goats had abnormal chloride
channel kinetics due to ion channel protein mutations.24 This finding, along with myotonic
mice studies,25 led to the prediction of the location of the Becker myotonia gene in
humans26 before the major chloride channel in mammalian skeletal muscle had been
cloned.27
Burmese pythons (Python molurus) also mimic and accentuate aspects of human disease
conditions with their unique responses after ingesting large prey. Fasting pythons have
reduced stomach volume, decreased intestinal mass, and ‘normal’ heart volumes. However
within 48–72 hours after feeding, pythons undergo massive remodeling of their entire
digestive system and a 40% increase in heart mass.28 Most mammalian models of
hypertrophy, on the other hand, only exhibit modest myocardial hypertrophy (~10–20%)
after weeks of stimulation.29, 30 These responses in pythons allow them to serve as unique
models of digestive physiology, metabolic regulation, and cardiac hypertrophy. Thus far,
studies show that python heart growth is characterized by myocyte hypertrophy in the
absence of cell proliferation through the activation of signaling pathways for fatty acid
transport and oxidation.31 A combination of fatty acids, identified in python plasma
following ingestion of a large meal, promotes hypertrophy in mammalian cardiac
myocytes.31 This finding suggests the possibility that fatty acid supplementation might
provide a new mechanism to modify cardiac gene expression and function and could be used
to enhance cardiac performance in humans with cardiovascular disease.
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Thus, in accordance with Krogh’s principle, the understanding of human health and disease
has been greatly aided by investigations of animal species with extraordinary evolved
phenotypes. With this in mind, the National Heart, Lung, and Blood Institute (NHLBI) in
2006 released two funding opportunity announcements entitled “Elucidating Nature’s
Solutions to Heart, Lung, and Blood Diseases and Sleep Disorder Processes.”32, 33 The
overall goal was to support “studies that elucidate the natural molecular and cellular
adaptations of mammalian species to extreme environmental conditions that would rapidly
evoke life-threatening cardiovascular or respiratory responses in other species, including
humans” with the objective of identifying “new therapeutic targets to treat and prevent heart,
lung, blood, and sleep disorders.” This initiative underscored Krogh’s principle by explicitly
supporting the study of animal species with evolved mechanisms that facilitate their survival
in conditions that mimicked or would normally result in human cardiovascular, respiratory,
blood, and sleep disorders. The initiative encouraged comparative biologists, a group of
investigators who had not traditionally been NIH-supported, to adapt their unique research
models towards understanding the basis of human diseases with the hope of identifying new
therapeutic targets. Seven studies (Table 1) were funded to examine the protective
mechanisms evolved by hibernating mammals; fish that stop normal development (undergo
diapause) under dehydrating conditions; high-altitude mice; and diving mammals. Although
these animal species endure a diverse range of environmental challenges, they exhibit
survival strategies that involve common pathways used by other species for metabolic
regulation, organ function maintenance, antioxidant defenses, and O2 transport.
Hibernators
Hibernation is a successful survival strategy employed by many species. For instance,
mammalian hibernators in harsh winter conditions intolerable to other species and humans
typically reduce their metabolism to ~1% of normal rates, decrease heart rate to ~5% of
normal values, and suppress body temperatures to as low as −2°C without apparent harm.34
Unlike non-hibernators and humans,35 cold-climate hibernators selectively maintain vital
organ function (e.g., brain and heart) and are not susceptible to detrimental cardiovascular
effects resulting from the low temperatures.36–38 Distinguishing characteristics of the
hibernator’s heart that differ from that of the non-hibernator include the activation of
signaling pathways elicited by ischemic preconditioning;37, 39 changes in electrical
properties;40, 41 maintenance of Na+/K+ ion homeostasis;42 and proteome alterations.43
During arousal from hibernation, hibernators do not suffer tissue damage resulting from
oxidative stress as experienced in non-hibernators.44–46 Future research to determine the
mechanisms that allow hibernators to survive dramatic seasonal changes will likely require
elucidating the differential expression of mRNAs and proteins, as well as protein post-
translational modifications, which distinguish summer-active animals from their winter-
hibernating counterparts. Further studies will elucidate how non-hibernators can be
protected from ischemia/reperfusion injury when they are induced to enter a reversible
hibernation-like (i.e., hypometabolic) state with hydrogen sulfide (H2S), which acts as a
vasodilator in the heart.47, 48 Such a strategy might be applied to patients suffering out-of-
hospital cardiac arrest or severe traumatic injury, permitting them to be placed in a state of
medically-induced hibernation so that more time could be taken to transport them to an
emergency department or hospital facility where advanced life-saving interventions,
including surgery, would be initiated.49 Understanding the strategies that allow hibernators
to dramatically reduce their metabolic rates and tolerate cold temperatures may also result in
development of better methods to preserve human organs prior to transplantation,50, 51
improved resuscitation outcomes,49 insight for protection against ischemia/reperfusion
injury,51, 52 and care for patients exposed to severe accidental hypothermia.53
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Anoxia-Tolerant Species That Suspend Development in Adverse
Conditions
Study of the evolved physiological mechanisms in species tolerant to O2 deprivation may
also contribute to the development of new therapeutic strategies to minimize morbidity and
mortality in patients suffering out-of-hospital cardiac arrest and severe traumatic injury.54
Anoxia- and hypoxia-tolerant species appear to share several characteristics (e.g., higher
hemoglobin (Hb)-O2 saturation, lower metabolic rate, blood flow redistribution, and
optimization of O2 usage). One survival strategy adapted by animal species that normally
endure prolonged O2 deprivation is to enter diapause (i.e., developmental arrest). Diapause
occurs in a number of species, but it is most often observed in arthropods and egg-laying
fish (e.g., annual killifish Austrofundulus limnaeus).55 The specific biochemical signaling
pathways that regulate metabolic control and stress tolerance during diapause vary from
organism to organism, but they share some common properties, which include a termination
signal before development resumes and the accumulation of molecular chaperones (i.e., heat
shock proteins).56 Other processes likely involved in diapause and in the regulation of
biochemical pathways that exist in all animal species include metabolic control by adenosine
monophosphate-activated protein kinase57 and/or phosphoenolpyruvate carboxykinase,58 as
well as ROS/reactive nitrogen species signaling resulting in post-translational modifications
that affect protein activity.59 These pathways are being further investigated at the molecular
level;56 and insights gained from these studies will complement current knowledge of these
processes in other animal species. Studies of mitochondrial physiology in diapausing species
suggest that intrinsic regulation of electron transport and proton leak across the inner
mitochondrial membrane may underlie anoxia tolerance,60 a mechanism that might someday
be triggered and employed in patients suffering chronic obstructive lung disease.
Elucidation of the mechanisms that initiate and maintain diapause has contributed to the
understanding of early human embryonic growth, delayed embryo transplantation, and
cryopreservation.61, 62 In future work with anoxia-tolerant species, it will be important to
determine how metabolic depression results in reduced energy consumption; identify what
pathways support anaerobic metabolism; understand how mitochondrial physiology is
regulated during anoxia/hypoxia; and explore the role of transcription factors/miRNA/
epigenetics in anoxia tolerance.
High-Altitude Inhabitants
Animal species that have adapted to life at high altitudes also serve as models for elucidating
the cellular and molecular mechanisms of tolerance to hypoxia-induced hypoxemia similar
to conditions experienced by humans with anemia or COPD.63, 64 For instance, deer mice
that are native to altitudes >4000 meters have evolved elevated Hb-O2 affinities relative to
their lowland counterparts, which help to safeguard arterial O2 saturation under hypoxic
conditions.65–67 The chronic hypoxia experienced by animal species that dwell at high
altitude is similar to that observed in patients with conditions resulting in insufficient blood
flow (e.g., cerebrovascular hemorrhage, vascular occlusion, cardiac arrest, or bypass
surgery) or respiratory dysfunction (e.g., airway obstruction, asthma, emphysema, or lung
dysfunction). Identifying and characterizing the molecular mechanisms of Hb adaptation to
hypoxia, for instance, may guide the design of recombinant Hbs for use as O2-carriers to
enhance tissue O2 supply in patients suffering hemorrhagic shock, hemolysis, and ischemic
insult in humans.68, 69 Further studies of adaptive changes in blood-O2 transport at high
altitude could also aid the development of new therapeutic interventions for high-altitude-
induced sleep apnea70 and various forms of chronic mountain sickness (CMS).71, 72 The
most prominent characteristic of CMS is excessive polycythemia, which leads to blood
hyperviscosity, pulmonary hypertension, cerebral hypoperfusion, heart failure, and
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death.71, 72 Pharmacological interventions to reduce and prevent the CMS erythropoietic
response are currently available,73 but a safe and effective therapeutic approach to CMS for
large-scale use remains lacking.74 The challenge for future hypoxia research is to explore
the cellular mechanisms and conditions that reconfigure an organ or cellular network into a
hypometabolic state.
Diving Mammals
Diving mammals endure a variety of environmental stresses, and they have evolved
physiological mechanisms that result in changes in respiratory drive, blood flow distribution,
and heart rate to permit them to tolerate long periods of activity underwater without inhaling
oxygen.75, 76 Understanding these reflex responses and how they may be employed in
patients has provided therapeutic interventions. For example, an induced “diving reflex” is a
recognized therapeutic intervention useful in terminating supraventricular tachycardia, a
sustained arrhythmia, in children.77, 78 Increased understanding of the mechanisms that
allow diving mammals to remain submerged for long durations and tolerate periods when
arterial blood oxygen tension (pO2)drops to anoxic levels in humans and land mammals
might be useful in understanding, treating, and preventing some cardiovascular disorders
and sleep disorders. During extended dives, coronary blood flow in seals may decrease to as
low as ~10% of pre-dive values79—a level comparable to that observed in infarcted dog
myocardium80—and arterial pO2 may be less than 20 torr.81 To prevent arterial blood pO2
from falling, diving mammals dramatically elevate myoglobin content in their skeletal and
cardiac muscle.76 To manage reductions in coronary blood flow while diving, the seal heart
relies largely on its large glycogen stores for fuel, resulting in lactate and H+ ion
accumulation.79, 82 Upon resurfacing, the myocardium resumes using lactate as fuel and
shows no evidence of ischemic dilation of the left ventricle or S-T segment elevation.83
Elevated antioxidant levels in the blood and tissue of diving mammals may in part counter
oxidative stress resulting from the rapid apnea to reoxygenation transition during
diving.84, 85 Understanding the mechanisms of how diving seals mobilize their high
glycogen stores for fuel82 could aid in identifying therapeutic targets treatment of glycogen
storage diseases in humans, where defects in muscle glycogen synthesis or breakdown result
in protein degradation, atrophy, hypertrophic cardiomyopathy, cardiomyocyte degeneration,
and fibrosis.86 Sleep apnea research might also benefit from the study of seals that are
apneic for most of their sleep time with arterial pO2 falling precipitously from a maximum
of 108 torr to a minimum of 18 torr.81, 87 Despite the increased prevalence and heightened
awareness, obstructive sleep apnea (OSA) is still underdiagnosed and appears to be
associated with diabetes, coronary heart disease, heart failure, and cardiac arrhythmias.88–90
The number of patients with obese-hypoventilation syndrome (OHS), characterized by
obesity, hypoventilation, and sleepiness, is rising.91 OHS treatment options and long-term
outcomes have been poorly studied,91 and diving mammals may provide ideal animal
models to better understand OSA and OHS.92
In addition to improving our understanding of sleep apnea, the study of seals might
contribute to increased understanding of insulin resistance in people. Post-weaned elephant
seal pups experience prolonged fasts of 8–12 weeks when unattended by their mothers,93
and as a result, the pups become insulin resistant.94, 95 Yet, elephant seals have evolved
mechanisms that permit fasting pups to continue to appropriately normalize carbohydrate
and blood glucose levels.96, 97 Elucidation of these processes for glucose regulation in
diving mammals could result in improved treatments for diabetes in people.98
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Conclusions
Evolution has produced a diverse array of animal species with unique phenotypes that
provide extraordinary models for understanding human disease processes and clues for the
development of new, effective means for the early identification, treatment, and prevention
of disease. In this way, these unique animal species fulfill Krogh’s principle. The NHLBI-
supported studies of animal species adapted to survive severe environmental conditions,
which mimic or would result in human heart, lung, blood, and sleep disorders, are
demonstrating that the mechanisms used by these species for metabolic regulation, organ
function maintenance, antioxidant defenses, and O2 transport have great potential for the
development of new treatments for human disorders. These examples, along with the past
successes of applying Krogh’s Principle to the study of animal species with extraordinary
phenotypes, underscore the power of employing nature’s solutions to guide the development
of novel therapies to treat and prevent human disease.
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